Enhancing Detection of Patients Eligible for Clinical Trials with Pierre Pellier CTMA TRANSCRIPT
Download PDFJun 21, 2021
Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.
Using the CT-Scout platform on a...
Jun 21, 2021
Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.
Using the CT-Scout platform on a...
Accurately Predicting Nature of Cardiac Toxicity of a Drug With Bob Hutchens StemBioSys TRANSCRIPT
Download PDFDec 7, 2020
Bob Hutchens, President and CEO, StemBioSys talks about their work building a set of tools that are being used around the world by pharmaceutical companies in early-stage drug discovery. CELLvo and CELLvo Matrix Plus are technologies that grow cells from amniotic fluid from natural births and reverse-engineer them into...
Dec 7, 2020
Bob Hutchens, President and CEO, StemBioSys talks about their work building a set of tools that are being used around the world by pharmaceutical companies in early-stage drug discovery. CELLvo and CELLvo Matrix Plus are technologies that grow cells from amniotic fluid from natural births and reverse-engineer them into...
Standardized Platform with Human Skin Tissue for Drug Testing with Pascal Descargues Genoskin TRANSCRIPT
Download PDFJul 27, 2020
Pascal Descargues PhD, Founder and CEO, Genoskin talks about bringing the only living injectable human platform to the market to enable clinical testing of drugs for efficacy and toxicity by biotech and pharmaceutical companies. Their standardized platform uses real human skin tissue to test the consequences of drugs...